Dan Donovan

Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ.

United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD.

Envision Pharma, Inc. operates as a medical and scientific communications company which provides solutions to the pharmaceutical and biotechnology industries. It offers consulting, technology, medical publications, and market access communication services. The company was founded by Brian Alexander Hepburn and Daniel J. Donovan on October 19, 2001 and is headquartered in Fairfield, CT.

Rarelife Solutions, Inc. offers integrated collaboration, science and technology consulting services. It also provides software and platform as a service (PaaS) solutions for advocacy groups, pharmaceutical and device companies, medical and research centers, and professional healthcare associations. The company was founded by Daniel J. Donovan and is headquartered in South Norwalk, CT.